Skip to main content

Chang Carmen's Form 4 filing

NeueHealth, Inc. (NEUE) · filed Oct 6, 2025

Accession no.
0001193125-25-232142
Filed
Oct 6, 2025, 5:52 PM ET
Trade date
Oct 2, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 17 non-derivative transactions and 14 derivative transactions. Open-market sales total $26.4K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Chang CarmenCIK 0001746342Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 2, 2025Common StockXIn-the-money exerciseAcquired+189,195$0.01+$1,891.95788,259IndirectDuplicate filing
Oct 2, 2025Common StockSSaleDisposed−280$6.75−$1,890787,979IndirectDuplicate filing
Oct 2, 2025Common StockMOption exerciseAcquired+372,255$0.01+$3,722.551,160,234IndirectDuplicate filing
Oct 2, 2025Common StockFTax withholdingDisposed−551$6.75−$3,719.251,159,683IndirectDuplicate filing
Oct 2, 2025Common StockDReturned to the companyDisposed−1,159,683–F3–0IndirectDuplicate filing
Oct 2, 2025Common StockXIn-the-money exerciseAcquired+189,195$0.01+$1,891.95488,982IndirectDuplicate filing
Oct 2, 2025Common StockSSaleDisposed−280$6.75−$1,890488,702IndirectDuplicate filing
Oct 2, 2025Common StockMOption exerciseAcquired+186,128$0.01+$1,861.28674,830IndirectDuplicate filing
Oct 2, 2025Common StockFTax withholdingDisposed−276$6.75−$1,863674,554IndirectDuplicate filing
Oct 2, 2025Common StockDReturned to the companyDisposed−674,554–F3–0IndirectDuplicate filing
Oct 2, 2025Common StockXIn-the-money exerciseAcquired+1,656,789$0.01+$16,567.891,656,789IndirectDuplicate filing
Oct 2, 2025Common StockSSaleDisposed−2,455$6.75−$16,571.251,654,334IndirectDuplicate filing
Oct 2, 2025Common StockXIn-the-money exerciseAcquired+607,536$0.01+$6,075.362,261,870IndirectDuplicate filing
Oct 2, 2025Common StockSSaleDisposed−900$6.75−$6,0752,260,970IndirectDuplicate filing
Oct 2, 2025Common StockMOption exerciseAcquired+124,085$0.01+$1,240.852,385,055IndirectDuplicate filing
Oct 2, 2025Common StockFTax withholdingDisposed−182$6.75−$1,228.52,384,873IndirectDuplicate filing
Oct 2, 2025Common StockDReturned to the companyDisposed−2,384,873–F3–0IndirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 2, 2025Common StockXIn-the-money exerciseDisposed−189,195$0.00$00IndirectDuplicate filing
Oct 2, 2025Common StockAGrant or awardAcquired+372,255–F7–372,255IndirectDuplicate filing
Oct 2, 2025Common StockMOption exerciseDisposed−372,255$0.00$00IndirectDuplicate filing
Oct 2, 2025Common StockXIn-the-money exerciseDisposed−189,195$0.00$00IndirectDuplicate filing
Oct 2, 2025Common StockAGrant or awardAcquired+186,128–F7–186,128IndirectDuplicate filing
Oct 2, 2025Common StockMOption exerciseDisposed−186,128$0.00$00IndirectDuplicate filing
Oct 2, 2025Common StockDReturned to the companyDisposed−330,194–F3–0IndirectDuplicate filing
Oct 2, 2025Common StockDReturned to the companyDisposed−509,780–F3–0IndirectDuplicate filing
Oct 2, 2025Common StockXIn-the-money exerciseDisposed−1,656,789$0.00$00IndirectDuplicate filing
Oct 2, 2025Common StockXIn-the-money exerciseDisposed−607,536$0.00$00IndirectDuplicate filing
Oct 2, 2025Common StockAGrant or awardAcquired+124,085–F7–124,085IndirectDuplicate filing
Oct 2, 2025Common StockMOption exerciseDisposed−124,085$0.00$00IndirectDuplicate filing
Oct 2, 2025Common StockDReturned to the companyDisposed−550,323–F3–0IndirectDuplicate filing
Oct 2, 2025Common StockDReturned to the companyDisposed−1,352,200–F3–0IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Pursuant to the Agreement and Plan of Merger, dated as of December 23, 2024, by and among the Issuer, NH Holdings 2025, Inc. ("Parent") and NH Holdings Acquisition 2025, Inc. ("Merger Sub"), on October 2, 2025, Merger Sub merged with and into the Issuer with the Issuer surviving such merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to rollover agreements entered into between certain of the Reporting Persons and NH Holdings 2025 SPV, L.P. ("Ultimate Parent"), Parent and Merger Sub, each share of the Issuer's Common Stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") beneficially owned by the Reporting Persons was contributed to Ultimate Parent in exchange for limited partnership interests in Ultimate Parent. Each such share of the Issuer's Common Stock, Series A Preferred Stock and Series B Preferred Stock was then cancelled and ceased to exist.

Referenced by the price of 3 transactions in Table I and 4 transactions in Table II.

F7

Warrants issued pursuant to the Warrantholders Agreement, dated September 30, 2025 between the Issuer and the holders listed on Schedule 1 thereto, and the Credit Agreement, dated August 4, 2023, as amended by that certain Incremental Amendment No. 1, dated as of October 2, 2023, that certain Incremental Amendment No. 2, dated as of April 8, 2024, that certain Amendment No. 3, dated as of June 21, 2024, that certain Amendment No. 4, dated as of October 29, 2024, and that certain Amendment No. 5, dated as of September 30, 2025, between the Issuer and the lenders thereto.

Referenced by the price of 3 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)